Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
What You Need to Know Before You Apply
What is the purpose of this trial?
This study examines the quality of life in patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma. Collecting quality of life information from patients may help doctors learn more about the most common symptoms and concerns patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma may have.
Who Is on the Research Team?
Melody E Becnel
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete quality of life questionnaires at baseline
Follow-up
Participants complete quality of life questionnaires every 6 months for observational study participants or every month for treatment study participants
What Are the Treatments Tested in This Trial?
Interventions
- Quality-of-Life Assessment
- Questionnaire Administration
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator